59 results
Page 2 of 3
8-K
EX-99.1
u6pw0rwskzhlxk7z
5 May 22
Axcella Reports First Quarter Financial Results and Provides Business Update
7:41am
8-K
EX-99.1
4htuhsg
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
424B5
grcqgn0 qok
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
twjn m2c8h0
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-99.1
pngajc0zeozkb
10 Jan 22
Other Events
8:00am
8-K
EX-99.1
rf42d2wga0cqm11ye8
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-99.1
j7ulhr4hi28z5q3aee
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
EX-99.1
o8465l300cdh4m
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.2
c0j1wfr9
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
1zk6p wfhespyq6et
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
vcg rgg6hh64r4
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
EX-99.1
bt9b6l6
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
4jpl53hypj w0zbu394
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am